Percutaneous transluminal procedure for removing atheromatous plaque from the coronary arteries. Both directional (for removing focal atheromas) and rotational (for removing concentric atheromatous plaque) atherectomy devices have been used.
Endovascular procedure in which atheromatous plaque is excised by a cutting or rotating catheter. It differs from balloon and laser angioplasty procedures which enlarge vessels by dilation but frequently do not remove much plaque. If the plaque is removed by surgical excision under general anesthesia rather than by an endovascular procedure through a catheter, it is called ENDARTERECTOMY.
A technique utilizing a laser coupled to a catheter which is used in the dilatation of occluded blood vessels. This includes laser thermal angioplasty where the laser energy heats up a metal tip, and direct laser angioplasty where the laser energy directly ablates the occlusion. One form of the latter approach uses an EXCIMER LASER which creates microscopically precise cuts without thermal injury. When laser angioplasty is performed in combination with balloon angioplasty it is called laser-assisted balloon angioplasty (ANGIOPLASTY, BALLOON, LASER-ASSISTED).
Radiography of the vascular system of the heart muscle after injection of a contrast medium.
Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Techniques using laser energy in combination with a balloon catheter to perform angioplasty. These procedures can take several forms including: 1, laser fiber delivering the energy while the inflated balloon centers the fiber and occludes the blood flow; 2, balloon angioplasty immediately following laser angioplasty; or 3, laser energy transmitted through angioplasty balloons that contain an internal fiber.
The use of ultrasound to guide minimally invasive surgical procedures such as needle ASPIRATION BIOPSY; DRAINAGE; etc. Its widest application is intravascular ultrasound imaging but it is useful also in urology and intra-abdominal conditions.
The veins and arteries of the HEART.
The return of a sign, symptom, or disease after a remission.
Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.
Use of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of BALLOON DILATION in coronary arteries, ANGIOPLASTY, BALLOON, CORONARY is available.
Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.
The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.
The main artery of the thigh, a continuation of the external iliac artery.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
The degree to which BLOOD VESSELS are not blocked or obstructed.
The condition of an anatomical structure's being constricted beyond normal dimensions.
Hospitals organized and controlled by a group of physicians who practice together and provide each other with mutual support.
Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
Motion pictures of the passage of contrast medium through blood vessels.
Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
Obstruction of flow in biological or prosthetic vascular grafts.
Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.
The continuation of the femoral artery coursing through the popliteal fossa; it divides into the anterior and posterior tibial arteries.
Radiography of blood vessels after injection of a contrast medium.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
The vein which drains the foot and leg.
The region of the lower limb in animals, extending from the gluteal region to the FOOT, and including the BUTTOCKS; HIP; and LEG.
An alternative to amputation in patients with neoplasms, ischemia, fractures, and other limb-threatening conditions. Generally, sophisticated surgical procedures such as vascular surgery and reconstruction are used to salvage diseased limbs.
Pathologic deposition of calcium salts in tissues.
Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Endoscopic examination, therapy or surgery performed on the interior of blood vessels.
Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.
The tunnel in the lower anterior ABDOMINAL WALL through which the SPERMATIC CORD, in the male; ROUND LIGAMENT, in the female; nerves; and vessels pass. Its internal end is at the deep inguinal ring and its external end is at the superficial inguinal ring.
Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.
Elements of limited time intervals, contributing to particular results or situations.
Narrowing or constriction of a coronary artery.
Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.
Narrowing below the PULMONARY VALVE or well below it in the infundibuluar chamber where the pulmonary artery originates, usually caused by a defective VENTRICULAR SEPTUM or presence of fibrous tissues. It is characterized by restricted blood outflow from the RIGHT VENTRICLE into the PULMONARY ARTERY, exertional fatigue, DYSPNEA, and chest discomfort.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
A clinically significant reduction in blood supply to the BRAIN STEM and CEREBELLUM (i.e., VERTEBROBASILAR INSUFFICIENCY) resulting from reversal of blood flow through the VERTEBRAL ARTERY from occlusion or stenosis of the proximal subclavian or brachiocephalic artery. Common symptoms include VERTIGO; SYNCOPE; and INTERMITTENT CLAUDICATION of the involved upper extremity. Subclavian steal may also occur in asymptomatic individuals. (From J Cardiovasc Surg 1994;35(1):11-4; Acta Neurol Scand 1994;90(3):174-8)
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
Mechanical devices that simulate the temporomandibular joints and jaws to which maxillary and mandibular casts are attached. The entire assembly attempts to reproduce the movements of the mandible and the various tooth-to-tooth relationships that accompany those movements.

Long-term functional status and quality of life after lower extremity revascularization. (1/81)

OBJECTIVE: The objective of this study was to assess the longer term (up to 7 years) functional status and quality of life outcomes from lower extremity revascularization. METHODS: This study was designed as a cross-sectional telephone survey and chart review at the University of Minnesota Hospital. The subjects were patients who underwent their first lower extremity revascularization procedure or a primary amputation for vascular disease between January 1, 1989, and January 31, 1995, who had granted consent or had died. The main outcome measures were ability to walk, SF-36 physical function, SF-12, subsequent amputation, and death. RESULTS: The medical records for all 329 subjects were reviewed after the qualifying procedures for details of the primary procedure (62.6% arterial bypass graft, 36.8% angioplasty, 0.6% atherectomy), comorbidities (64% diabetics), severity of disease, and other vascular risk factors. All 166 patients who were living were surveyed by telephone between June and August 1996. At 7 years after the qualifying procedure, 73% of the patients who were alive still had the qualifying limb, although 63% of the patients had died. Overall, at the time of the follow-up examination (1 to 7.5 years after the qualifying procedure), 65% of the patients who were living were able to walk independently and 43% had little or no limitation in walking several blocks. In a multiple regression model, patients with diabetes and patients who were older were less likely to be able to walk at follow-up examination and had a worse functional status on the SF-36 and a lower physical health on the SF-12. Number of years since the procedure was not a predictor in any of the analyses. CONCLUSION: Although the long-term mortality rate is high in the population that undergoes lower limb revascularization, the survivors are likely to retain their limb over time and have good functional status.  (+info)

Endovascular-assisted versus conventional in situ saphenous vein bypass grafting: cumulative patency, limb salvage, and cost results in a 39-month multicenter study. (2/81)

OBJECTIVE: In this retrospective multicenter study, the results of a minimally invasive method of endovascular-assisted in situ bypass grafting (EISB) versus "open" conventional in situ bypass grafting (CISB) were evaluated with a comparison of primary and secondary patency, limb salvage, and cost. METHODS: Enrolled in this study were 273 patients: 117 underwent CISB (42 femoropopliteal, 75 femorocrural) and 156 underwent EISB (41 femoropopliteal, 115 femorocrural). EISB was performed with an angioscopic Side Branch Occlusion system and an angioscopically guided valvulotome. All the patients underwent follow-up examination with serial color-flow ultrasound scanning. RESULTS: Both groups had similar comorbid risk factors for diabetes mellitus, coronary artery heart disease, hypertension, and cigarette smoking. The primary patency rates (CISB, 78.2% +/- 5% [SE]; EISB, 70.5% +/- 5%; P =.156), the secondary patency rates (CISB, 84.1% +/- 4%; EISB, 82.9% +/- 5%; P =.26), and the limb salvage rates (CISB, 85.8%; EISB, 88.4%; P =.127) were statistically similar, with a follow-up period that extended to 39 months (mean, 16.6 months; range, 1 to 40 months). In veins that were less than 2.5 to 3.0 mm in diameter, the EISB grafts fared poorly, with an increased incidence of early (12-month) graft thromboses (CISB, 10 grafts, 8.5%; EISB, 24 grafts, 15.3%). However, wound complications (CISB, 23%; EISB, 4%; P =.003), mean hospital length of stay (CISB, 6.5 days +/- 4.83; EISB, 3.2 days +/- 3.19; P =.001), and mean hospital charges (CISB, $25,349 +/- $19,476; EISB, $18,096 +/- $14,573; P =.001) were all significantly reduced in the EISB group. CONCLUSION: The CISB and EISB midterm primary and secondary patency and limb salvage rates were statistically similar. In smaller veins (< 2.5 to 3.0 mm in diameter), however, EISB is not appropriate because overly aggressive instrumentation may cause intimal trauma, with resultant early graft failure. With the avoidance of a long leg incision in the EISB group, wound complications and hospital length of stay were significantly reduced, which lowered hospital charges and justified the additional cost of the endovascular instruments. When in situ bypass grafting is contemplated, EISB in appropriate patients is a safe, minimally invasive, and cost-effective alternative to CISB.  (+info)

Peripheral directional atherectomy evaluated with a rotational digital angiography system. (3/81)

BACKGROUND: One of the factors that affect the recurrence rate after peripheral directional atherectomy (DA) is the degree of residual stenosis. A new method of peripheral DA to reduce residual stenoses was evaluated with a rotational digital angiography (RDA) system that provides both angiography and fluoroscopy at multiple projections within 360 degrees. PATIENTS AND METHODS: Between March 1995 and July 1999, severe short segmental stenoses of six iliac arteries and two superficial femoral arteries (SFA) in eight patients were treated with the Simpson DA catheter under RDA system guidance. After pre-procedural RDA evaluation, the first series of DA were performed under ordinary PA fluoroscopic guidance. The residual stenoses were evaluated with RDA. If the residual stenoses exceeded 30%, a second series of DA were performed covering the residual plaque with the cutter window of the DA catheter. To this purpose the fluoroscopy of the RDA system was fixed in the direction in which the residual stenoses were largest and most eccentric. The end point was defined to be a residual stenosis of less than 30% evaluated with the RDA system, and the procedures were repeated until the end point was achieved. RESULTS: Five of six iliac artery lesions were curved at the pre-procedural RDA evaluation. After the first series of DA, only two of six iliac lesions but all SFA lesions achieved the end point. Among the four other iliac lesions, three achieved the end point with one or two additional series of DA using the RDA system guidance to control the selective cuts of the residual plaques. One patient had a residual stenosis of 50% because the procedure could not be completed by balloon rupture of the DA catheter. In the patients with iliac stenoses, there was no final residual stenosis in one, and the range was from 20% to 25% in the four patients. The residual stenoses were located on the greater curvature side of the curved artery in three of these four patients. CONCLUSION: The RDA system is a valuable tool in aiding reduction of the residual stenoses during peripheral DA. Minimal stenoses often remain on the greater curvature side of the wall because the rigid and straight metallic capsule (cylindrical housing) of the Simpson DA catheter does not completely fit the curved wall. This phenomenon was thought to be a mechanical limitation of this device.  (+info)

A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). (4/81)

AIMS: Rotablation is a widely used technique for the treatment of complex coronary artery lesions but is so far only poorly supported by controlled studies. The Comparison of Balloon-Angioplasty versus Rotational Atherectomy study (COBRA) is a multicentre, prospective, randomized trial to compare short- and long-term effects of percutaneous transluminal coronary angioplasty (PTCA) and rotablation in patients with angiographically pre-defined complex coronary artery lesions. METHODS AND RESULTS: At seven clinical sites 502 patients with pre-defined complex coronary artery lesions were assigned to either PTCA (n=250) or rotablation (n=252). Primary end-points were procedural success, 6-month restenosis rates in the treated segments, and major cardiac events during follow-up. Procedural success was achieved in 78% (PTCA), and 85% (rotablation) (P=0.038) of cases. Crossover from PTCA to rotablation was 4% and 10% vice versa (P=0.019). There was no difference between PTCA and rotablation with respect to procedure-related complications such as Q wave infarctions (2.4% each), emergency bypass surgery (1.2% versus 2.4%), and death (1.6% versus 0.4%). However, more stents were required after PTCA (14.9% versus 6.4%, P<0.002), predominantly for bailout or unsatisfactory results. Including bail-out stents as an end-point, the procedural success rates were 73% for angioplasty and 84% for rotablation (P=0.006). At 6 months, symptomatic outcome, target vessel reinterventions and restenosis rates (PTCA 51% versus rotablation 49%, P=0.33) were not different. CONCLUSION: Complex coronary artery lesions can be treated with a high level of success and low complication rates either by PTCA with adjunctive stenting or rotablation. The long-term clinical and angiographic outcome is comparable.  (+info)

Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. (5/81)

BACKGROUND AND PURPOSE: We sought to quantitatively and qualitatively evaluate the release of atheromatous plaque debris induced by carotid stenting procedures. METHODS: Eight patients with severe carotid atheromatous stenoses were treated by stent implantation under distal balloon protection. Blood samplings were obtained after stent deployment in the blood pooled below the inflated protection balloon. The samples were centrifuged and evaluated for plaque debris with the use of light microscopy. The debris release was quantitatively estimated by dividing the total volume of debris obtained by the mean debris size. Five patients without endovascular procedure were used as a control group. RESULTS: The 2 main debris types found were nonrefringent cholesterol crystals (4 to 389 microm; 115 to 8697 in number) and lipoid masses (7 to 600 microm; 341 to 34 000 in number). There was a statistically significant difference compared with the samples obtained in the control group (P:=0.017). CONCLUSIONS: Blood samples collected during stent implantation procedures contain a large quantity of atheromatous plaque debris. This emphasizes the role of distal protection techniques in avoiding migration of this plaque material into the cerebral circulation.  (+info)

A novel approach in treating recurrent bilateral hepaticojejunostomy biliary strictures post-liver transplantation: Successful use of Simpson's atherectomy device. (6/81)

Biliary complications occur in 6% to 34% of patients who undergo orthotopic liver transplantation. Strictures at the anastomosis site or elsewhere in the biliary tract are common. These strictures are amenable to interventional radiological and surgical procedures; however, retransplantation is sometimes an inevitable outcome. An 8-year-old boy received combined liver and kidney transplants May 31, 1998. Hepatic artery thrombosis was diagnosed postoperative day 1 and treated with revascularization. The choledochojejunostomy was revised twice and resulted in a high hepaticojejunostomy. Significant strictures on both the right and left hepatic ducts at the anastomosis site were unsuccessfully treated by multiple interventional radiological procedures. The option of retransplantation was seriously explored. Simpson's atherectomy device was used in a novel approach February 24, 1999, and strictures on both ducts were successfully treated. At 1-year postprocedure, the patient has normal liver function with no evidence of recurrence of the strictures. Further experience with this novel technique is required to assess its role in treating biliary strictures post liver transplantation.  (+info)

Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997). (7/81)

This retrospective, observational, single-center study analyzed the results of a "stent-when-feasible" policy in a real-world setting. The study began in the "pre-stent" period (1993) and ended after the beginning of the "routine stent" period (1997). When the 1993 and 1997 global data were compared, the early and 6-month results included significant improvements in the rates of angiographic success (89.3% vs 97.1%), emergency surgical revascularization (1.0% vs 0.3%), freedom from in-hospital major events (91.2% vs 95.9%), and freedom from 6-month major events (77.2% vs 85.1%). The 6-month redo revascularization rate was reduced by almost half for "any catheter intervention" (19.6% vs 10.7%) and was lowest after stent use (7.7% in 1997).  (+info)

Percutaneous transluminal revascularization for renal artery stenosis: Veterans Affairs Puget Sound Health Care System experience. (8/81)

PURPOSE: The safety and efficacy of percutaneous transluminal intervention for renal artery stenosis is improving. This study evaluates the immediate and long-term anatomic and functional outcomes of percutaneous transluminal angioplasty and stenting for atherosclerotic renal artery stenosis in a Veterans Affairs population. METHODS: We performed a retrospective analysis of records from patients who underwent renal artery angioplasty with or without stenting at the Veterans Affairs Puget Sound Health Care System between January 1990 and June 1999. Indications for intervention included hypertension (78%) and rising serum creatinine (78%). Seventy-six patients (74 men, average age of 67 years, range 42-83 years) underwent 88 attempted interventions. Seventy-two percent of contralateral kidneys had significant disease (47% had a >60% stenosis; 16% were nonfunctioning or absent). RESULTS: Of the 88 planned interventions, 86 were successfully performed with placement of 46 stents (52%). Technical success (defined by <30% residual stenosis) was achieved in 78 vessels (89%). The procedure-related complication rate was 5%. Patient mortality by life table analysis was 49% at 5 years. Assisted primary patency rate at 5 years was 100%. Primary and secondary restenosis rates were 37% +/- 8% and 31% +/- 8% at 5 years, respectively. Sixty-eight percent of patients treated for hypertension demonstrated clinical benefit (improved or cured hypertension). This clinical benefit was maintained in 52% of the patients at 5 years, as measured by life table analysis. Serum creatinine was lowered or maintained in 88% of the patients, but this clinical benefit was only maintained in 25% of patients at 5 years. CONCLUSIONS: Transluminal intervention for clinically symptomatic atherosclerotic renal artery stenosis is technically successful and safe. There are excellent assisted-patency and low restenosis rates. There is immediate clinical benefit for most patients, as evidenced by improved control of hypertension and preservation of renal function. However, within 5 years the benefit is not maintained for either hypertension (50%) or renal function (20%). Therefore, although technically successful, functional outcomes after endoluminal intervention are not maintained in the long term.  (+info)

Global Laser Atherectomy Devices Market which allows the consumer to assess the long-term based demand and estimate particular implementations. The increasing growth which is truly expected depending on the analysis gives comprehensive information on the global Laser Atherectomy Devices Market. The drivers and restraints are preparing after the whole awareness of the global Laser Atherectomy Devices industry growth.. Global Laser Atherectomy Devices market research report provides the newest industry data and industry future trends. It permits you to recognize the products and complete users managing Revenue growth and profitability. The Laser Atherectomy Devices industry report lists the leading competitors and provides the game-changing strategic analysis of the key factors driving the market. The report involves the forecasts by 2020-2029 and analysis of significant industry trends, market size, market share forecasts, and profiles of the top Laser Atherectomy Devices industry players.. FREE ...
The research report presents a comprehensive outlook on the Global Laser Atherectomy Devices Market contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications. The Laser Atherectomy Devices Market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.It furthermore has an assessment of the factors influencing the demand and supply of the associated products and services, and challenges witnessed by market players. Moreover, the report is made with different graphical representation with the precise arrangement of key outlines, strategic diagrams, and descriptive figures based on the reliable ...
[96 Pages Report] Check for Discount on United States Laser Atherectomy Devices Market Report 2017 report by QYResearch Group. In this report, the United States Laser Atherectomy Devices market...
The global Orbital Atherectomy Device Market report provides an accurate investigation of the different patterns and parameters affecting the industrial growth of the Orbital Atherectomy Device market at a global level. An assessment of the effect of the current situation and trends in the market is additionally included to provide an overview of the markets future position. The report provides the detailed information related to the global Orbital Atherectomy Device market dynamics and demonstrates superior forecast for the development of the market and its key competitors Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), Avinger (US) based on consistent information.. Apply here for the sample copy of the report @: www.99strategy.biz/request-for-sample.html?repid=46491. Furthermore, The report presents a detailed segmentation Peripheral Vascular, Cardiovascular, ...
An atherectomy device is used for removing a restriction in a blood vessel. The atherectomy device includes a cutting portion having a lumen therein, the lumen being sized to track over a guidewire, wherein an outer surface of the cutting portion comprises a cutting surface. An elongate shaping member is cooperable with the cutting portion and is disposed generally longitudinally relative to the cutting portion. The shaping member has an insertion conformation and an expanded conformation. The expanded conformation is radially expanded relative to the insertion conformation. The shaping member is configured to deform the cutting portion from an insertion shape into a cutting shape as the shaping member moves from the insertion conformation to the expanded conformation. A drive shaft is coupled to a proximal end of the cutting portion and is configured to be rotationally driven.
The Global Atherectomy Devices Market is expected to reach USD 894.69 million by 2025, based on a new report by Hexa Reports. The demand for atherectomy de
A rotational atherectomy device for removing a stenotic tissue from a vessel of a patient is disclosed. The device comprises a rotatable, flexible, hollow drive shaft having a fluid impermeable wall defining a fluid impermeable lumen of the drive shaft and, an abrasive element mounted to a distal end portion of the drive shaft proximal to and spaced away from a distal support element formed at a distal end of the drive shaft, the distal support element being inflatable by pressurized fluid which flows in an antegrade direction through said lumen of the drive shaft and is at least partially re-directed into the distal fluid inflatable support element. The distal fluid inflatable support element has an outer wall comprising an outflow opening located such that said outflow opening faces an inner surface of a treated vessel during rotation of the drive shaft so that a flow of fluid through said outflow opening forms a layer of fluid between the outer wall of the rotating fluid inflated distal support
Press release - Market Expertz - Atherectomy Devices Market Size, Share Growth, Trends, Devices, Applications, Competitive Analysis, Industry Expansion Strategies, By 2027 - published on openPR.com
Medtronic has been granted CE mark approval for the HawkOne directional atherectomy system in a lower profile size for treating patients with peripheral artery disease. The new HawkOne 6 Fr provides an effective and easy-to-use treatment option for patients with peripheral artery disease both above and below the knee with a single device. The HawkOne system is designed to remove plaque from the vessel wall and restore blood flow.. Directional atherectomy is an established treatment modality for patients with complex peripheral artery disease to restore patency, maximise luminal gain and preserve future treatment options, says Thomas Zeller, head, Department of Angiology, Universitäts-Herzzentrum Freiburg, Bad Krozingen, Germany. The new smaller HawkOne 6Fr size is an advanced option to treat patients with multi-level peripheral artery disease, addressing lesions of various length, morphology, and location, particularly those below the knee.. The HawkOne system is also designed to enable ...
This medical exhibit illustrates the Atherectomy Procedure. The atherectomy instrument is visualized within the coronary artery shaving away the atherosclerotic plaque .
We treat Peripheral arterial disease with minimally invasive state of the art tools. Often at times patients are treated by surgical bypass when they suffer from blockages in the legs. However we use tools such as CSI atherectomy, SilverHawk atherectomy devices for opening up these blocked vessels ...
However, being able to visualize the vessel with the lumivascular technology is clearly appealing and suggestive of safe passage. Distal embolization remains a major concern (especially atherectomy for ISR), and questions the need for embolic protection every time (filter was used only in 22% of patients in the DEFINITVE LE trial).7 Unprecedented complications can arise, which require expertise and catheter skills and may lead to the possibility of open vascular surgery in these high-risk patients.. DA in ISR lesions have been contraindicated due to the potential risk of cutter entrapment on stent struts during atherectomy. However, with the advent of concurrent imaging during DA, this risk can potentially be avoided. Nevertheless, as seen in this case, despite adequate visualization with OCT imaging, there can be significantly malapposed stent struts in overlapped segments that may still pose a risk for trapping the DA catheter. In such scenarios, the use of adjunctive balloon angioplasty ...
Evidence-based recommendations on percutaneous laser atherectomy with balloon angioplasty (with or without stenting) for peripheral arterial disease (PAD)
Evidence-based recommendations on percutaneous laser atherectomy with balloon angioplasty (with or without stenting) for peripheral arterial disease (PAD)
An atherectomy apparatus and method is disclosed for the purpose of surgical excision of atheromas which typically consist of plaque deposits that cause narrowing (stenosis) of an artery. The apparatus, called a pullback atherectomy catheter, cuts and collects obstructive material into a collection chamber as the catheter is pulled back through obstructive material within a human vessel such as an artery.
An atherectomy system for cutting, ingesting and removing an obstruction from within a patients artery, comprising a flexible guide-wire insertable into the artery, a flexible rotary-catheter rotatably disposed and slidable over the flexible guide-wire, a blade forming a distal end of the flexible rotary-catheter having teeth on its periphery which are bent inward, a continuous passage for ingesting the cut obstruction material between the flexible rotary-catheter and the flexible guide-wire, means at the proximal end of the flexible rotary-catheter for rotating it and positive displacement pump means connected to the continuous passage to pull the cut obstruction material proximally.
Avinger has received 510(k) clearance from the US Food and Drug Administration (FDA) for an enhanced version of its Pantheris lumivascular atherectomy system, an image-guided atherectomy device for the treatment of peripheral arterial disease. Avinger will commence US commercialisation of this enhanced version of Pantheris immediately, which the company says features improved ergonomics, physician controls and manufacturability.. Lumivascular technology utilised in the Pantheris system allows physicians to see from inside the artery during a directional atherectomy procedure by using optical coherence tomography (OCT). In the past, physicians have had to rely solely on X-ray as well as touch and feel to guide their tools while they try to treat complicated arterial disease. With the lumivascular approach, physicians can more accurately navigate their devices and treat peripheral arterial disease lesions, thanks to the OCT images they see from inside the artery, according to an Avinger press ...
An atherectomy catheter is provided having a tissue collection chamber capable of being cleaned out in a simple, fast and effective way, and also provides methods of using said catheter to remove material from a blood vessel lumen. In one embodiment the tissue collection chamber has an expandable tip having a first closed position capable of retaining material in the chamber and having a second open position that may allow expulsion of material from the chamber. In a second embodiment the tissue collection chamber has a displaceable tip having a first closed position to retain material in the chamber and having a second open position to allow expulsion of material from the chamber.
A vascular catheter includes a flexible catheter body having proximal and distal ends and an elongate housing secured to the distal end of the catheter body. An interactional device is disposed on one side of the housing, and at least two spaced-apart inflatable chambers are located on the other side of the housing generally at its proximal and distal ends, respectively. The inflatable chambers may be expanded simultaneously or separately, and the spaced-apart positioning of the chambers provides for stable positioning of the housing during atherectomy procedures, imaging procedures, and the like. The balloon is conveniently connected to the housing by an integral flange structure which is secured through an inflation aperture on the housing side. The balloon may be inflated through an annular inflation which is defined by a separate isolation tube disposed in the central lumen of the catheter body.
ECCENTRIC ABRADING HEAD FOR HIGH-SPEED ROTATIONAL ATHERECTOMY DEVICES - The invention provides a rotational atherectomy device having, in various embodiments, a flexible, elongated, rotatable drive shaft with at least one flexible eccentric enlarged abrading head attached thereto. In other embodiments, the eccentric abrading head is not flexible or partially flexible. At least part of the eccentric enlarged cutting head has a tissue removing surface-typically an abrasive surface. In certain embodiments, the abrading head will be at least partially hollow. When placed within an artery against stenotic tissue and rotated at sufficiently high speeds the eccentric nature of the enlarged cutting head causes the cutting head and drive shaft to rotate in such a fashion as to open the stenotic lesion to a diameter substantially larger than the outer diameter of the enlarged cutting head. Preferably the eccentric enlarged cutting head has a center of mass spaced radially from the rotational axis of the ...
An arterial catheter system for removing plaque from the aorta and other arteries is disclosed. The system typically includes an elongate catheter member, a filtration apparatus disposed within the di
A cylindrical housing has a plurality of seriate slots. A helical cutter is rotatably mounted within the housing. A drive wire passes through the housing and connects with the cutter to provide rotational movement to the cutter. Plaque is caught between the slots and the blades of the rotating cutter, cut away from the arterial wall, ground up and flushed out through a catheter.
A system and method for opening a lumen in an occluded blood vessel, e.g., a coronary bypass graft, of a living being. The system comprises an atherectomy catheter having a working head, e.g., a rotary impacting impeller, and a debris extraction sub-system. The atherectomy catheter is located within a guide catheter. The working head is arranged to operate on, e.g., impact, the occlusive material in the occluded vessel to open a lumen therein, whereupon some debris may be produced. The debris extraction sub-system introduces an infusate liquid at a first flow rate adjacent the working head and withdraws that liquid and some blood at a second and higher flow rate, through the guide catheter to create a differential flow adjacent the working head, whereupon the debris is withdrawn in the infusate liquid and blood for collection outside the beings body. The introduction of the infusate liquid may also be used to establish an unbalanced flow adjacent the working head to enable the atherectomy catheter to
Endovascular interventions have significantly evolved over the past decades. Since the initial application of plain balloon or percutaneous transluminal angioplasty, several novel endovascular approaches and devices have been released on the market (for example, bare metal stents, cryoplasty, atherectomy devices, stent‐grafts, drug‐eluting stents, and drug‐eluting balloons). In general these devices have been studied in relatively small and selected patient populations, often not including CLI patients.62 The only RCT directly comparing open bypass surgery with endovascular therapy (ie, plain balloon angioplasty) in CLI patients is the BASIL trial, which overall showed no differences between the treatment groups with respect to AFS at 1 and 3 years of follow‐up based on an intention‐to‐treat analysis.4 Patients allocated to the open bypass surgery group surviving for more than 2 years after the initial procedure had improved AFS (adjusted HR 0.37; 95% CI 0.17-0.77; P=0.008) and ...
An improved expandable removal element (16) for an atherectomy device wherein the expandable removal element (16) is movable between an expanded position and a contracted position. In one embodiment o
The acquisition of Spectranetics will further expand and strengthen Philips Image-Guided Therapy Business Group. Spectranetics is a leader in vascular intervention to treat coronary and peripheral artery disease, and in lead management for the minimally invasive removal of implanted pacemaker and implantable cardioverter defibrillator (ICD) leads. Spectranetics is currently growing double digits and projects 2017 sales to be in the range of US$293 million to US$306 million.. Spectranetics device portfolio includes a range of laser atherectomy catheters for treatment of blockages with laser energy in both coronary and peripheral arteries; the AngioSculpt scoring balloon used to mechanically push a blockage aside in both peripheral and coronary arteries; the AngioSculptX scoring balloon, which is the only drug-coated scoring balloon in the market, and the Stellarex drug-coated balloon, which treats common to complex lesions while inhibiting the recurrence of these blockages. All of these market ...
The Willis-Knighton Heart & Vascular Institute provides the following Peripheral Vascular Disease Treatments Carotid Stents, Abdominal Aortic Aneurysm Stent Grafts, Renal Angioplasty & Stents, Peripheral Laser Atherectomy and Cryo-Balloon Angioplasty.
At Mission Vascular & Vein Institute Dr. Pedro Mego is equipped to treat even the most severe P.A.D. cases. With equipment such as SilverHawk, Pheonix, Diamondback360, and laser therapy Dr. Mego is able to tailor an invasive or non-invasive procedure to each individual patient.
Beretta a390 replacement shotgun forearms: used 40 caliber beretta gun price beretta silverhawk 20 gauge beretta 92 defects beretta automatic model date mfg. Some very powerful pistols are gas operated, or pack mule invariably had a Dutch.
The present invention provides an atherectomy catheter which has a cutting element that is able to cut both soft tissue and hard tissue, and methods of cutting material from a blood vessel lumen using a rotating cutting element. The cutting element has a sharp cutting edge that surrounds a cup-shaped surface and at least one surface of abrasive material. The cup-shaped surface directs the cut material into a tissue chamber. The cutting edge and the cup-shaped surface together are well suited to cut and remove relatively soft tissue from the blood vessel. The abrasive material surface in combination with the cutting element is well suited to abrade and remove hard material from the blood vessel.
This Histri was built automatically but not manually verified. As a consequence, the Histri can be incomplete or can contain errors ...
Atherectomy is a minimally invasive endovascular surgery technique for removing atherosclerosis from blood vessels within the body. It is an alternative to angioplasty for the treatment of peripheral artery disease, but the studies that exist are not adequate to determine if it is superior to angioplasty. It has also been used to treat coronary artery disease, albeit ineffectively. Atherectomy is used to treat narrowing in arteries caused by peripheral artery disease. Unlike angioplasty and stents, which push plaque into the vessel wall, atherectomy cuts plaque from the wall of the artery. While atherectomy is usually employed to treat arteries it can be used in veins and vascular bypass grafts as well. Atherectomy falls under the general category of percutaneous revascularization, which implies re-canalizing blocked vasculature via a needle puncture in the skin. The most common access point is near the groin through the common femoral artery (CFA). Other common places are the brachial artery, ...
Atherectomy led to better postprocedural luminal dimensions but was similar to angioplasty for 6-month outcomes in left anterior descending coronary arteries. Coronary atherectomy, endoluminal stenting, and laser angioplasty are alternative interventions to balloon angioplasty (PTCA) for the percutaneous revascularization of obstructive CAD. They were developed because of the persistent unacceptably high restenosis rate (30% to 50%) associated with PTCA. The Coronary Angioplasty versus Excisional Atherectomy Trial (CAVEAT) by Topol and colleagues and the Canadian Coronary Atherectomy Trial (CCAT) by Adelman and colleagues are important because they are the first randomized trials to compare PTCA with an alternative intervention device. In fact, only 2 other randomized trials with PTCA have been reported: the Angioplasty Compared to Medicine (ACME) trial in patients with single-vessel disease and the Randomized Intervention Treatment of Angina (RITA) trial comparing PTCA with bypass graft ...
Directional atherectomy was associated with a trend toward lower rates of restenosis at 6 months, and increased mortality and ischemic events at one year. DCA resulted in higher rates of early complications at a higher cost and with no clinical benefit. Paradoxically, initial dissemination of these study results produced a transient increase in use of directional atherectomy at CAVEAT-I sites. Among investigators in the trial, there may have been a lack of influence of trial data on clinical practice patterns 1 year after publication of the results.. ...
View details of top coronary atherectomy hospitals in Chennai. Get guidance from medical experts to select best coronary atherectomy hospital in Chennai
In addition to compressing and reshaping atheroma, atherectomy excises tissue and debulks plaques; it was anticipated that this mechanism would result in a lower rate of restenosis than that occurring after angioplasty. These expectations were not fulfilled in this trial. Although the procedural success rate was somewhat higher and the postprocedure lumen larger in patients treated with atherectomy, lumen dimensions, restenosis rates and clinical outcomes were similar in the two groups at six months. Clinical outcomes for the two groups were similar at up to 18 months after the procedure.. ...
TY - JOUR. T1 - Coronary angioplasty versus excisional atherectomy trial. T2 - CAVEAT. AU - Holmes, David. AU - Garratt, Kirk N.. AU - Topol, Eric J.. PY - 1992/1/1. Y1 - 1992/1/1. KW - Coronary angioplasty. KW - Exasional atherectomy. UR - http://www.scopus.com/inward/record.url?scp=0026575986&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0026575986&partnerID=8YFLogxK. U2 - 10.1016/0167-5273(92)90170-8. DO - 10.1016/0167-5273(92)90170-8. M3 - Editorial. C2 - 1572733. AN - SCOPUS:0026575986. VL - 35. SP - 143. EP - 146. JO - International Journal of Cardiology. JF - International Journal of Cardiology. SN - 0167-5273. IS - 2. ER - ...
TY - GEN. T1 - Assessment of possible thermal damage of tissue due to atherectomy by means of a mechanical debulking device. AU - Lovik, Ryan D.. AU - Abraham, John P.. AU - Sparrow, Ephraim M. PY - 2009/12/1. Y1 - 2009/12/1. N2 - In vitro and cadaver experiments, coupled with numerical simulations, were performed to assess the possibility mat orbital atherectomy might cause thermal damage of tissue. The experiments involved debulking operations on a surrogate artery and on the plaque-lined posterior tibial artery of a cadaver. Temperatures and coolant flow rates measured during these experiments enabled a numerical simulation of the debulking of a plaque-lined artery in a living human. The temperature variations from the numerical simulations were used to evaluate a thermal injury index. The resulting values of the index were found to be several orders of magnitude below the threshold value for thermal injury. It is concluded that it is extremely unlikely that the use of an orbital debulking ...
Arteriogram and Atherectomy Baltimore, MD - Minimally Invasive Vascular Center offers Arteriogram and Atherectomy services. Our practice serves Baltimore, MD, Laurel, MD, Silver Spring, MD and the surrounding areas.
Methods: The average age of the 40 patients (32 men, 8 women) included in this study was 65.4±9.1 years. The average occlusion length was 17.5 cm (range: 12-25 cm). The initial recanalization attempts were performed with stiff Terumo guidewires (curved or straight) supported by various catheters (straight/multipurpose/Cobra). After the unsuccessful attempt, an excimer laser catheter (catheter diameters from 1.7-2.5 mm) was used for recanalization using the step-by-step method of crossing. After successful crossing, balloon dilatation was performed in all cases. Stent implant was required in 10% (4/40) of procedures. Patients were followed for 12 months with colour-coded Duplex sonography (CCDS ...
Based in Atlanta, GA, Discovery is a leading health information services provider and one of the nations largest processors of third party medical record requests, including Release of Information, (ROI), and has agreements with hospitals, clinics and physician practices in over 40 states as a Health Information Handler, (HIH). They address the needs of both healthcare providers and authorized requestors to manage the rapidly expanding demand to fulfill HIPAA regulated patient, governmental, insurance, legal, and audit requests for medical records. Using a comprehensive, technology based solutions approach, they address the complexities and regulatory aspects of satisfying patient confidentiality while helping their customers reduce compliance risks, improve productivity and enhance profitability. Reach Discovery at (678) 990-5300 or visit - www.discoveryhrs.com ...
Rotational atherectomy by rotablator. The rotablator pulverize the calcified plaque of atheroma. Here, example of a coronary artery. - Stock Image C002/7142
Clinical Cases in Coronary Rotational Atherectomy: Complex Cases and Complications This concise practical guide is designed to facilitate the clinical
SYSTEM AND METHOD OF USE FOR AGENT DELIVERY AND REVASCULARIZING OF GRAFTS AND VESSELS - A system and method for opening a lumen in an occluded blood vessel, e.g., a coronary bypass graft, of a living being. The system comprises an atherectomy catheter having a working head, e.g., a rotary impacting impeller, and a debris extraction sub-system. The atherectomy catheter is located within a guide catheter. The working head is arranged to operate on, e.g., impact, the occlusive material in the occluded vessel to open a lumen therein, whereupon some debris may be produced. The debris extraction sub-system introduces an infusate liquid at a first flow rate adjacent the working head and withdraws that liquid and some blood at a second and higher flow rate, through the guide catheter to create a differential flow adjacent the working head, whereupon the debris is withdrawn in the infusate liquid and blood for collection outside the beings body. The introduction of the infusate liquid may also be used ...
Endovascular Today sat down with a multidisciplinary panel of esteemed interventionists to discuss their current practice paradigms for atherectomy, including the hot topic of Vessel Prep prior to drug-coated balloons and other adjunctive therapies.
COLORADO SPRINGS, Colo., June 4, 2014-- A presentation by principal investigator Eric J. Dippel, MD, of Genesis Heart Institute in Davenport, Iowa, at the annual New Cardiovascular Horizons conference in New Orleans last week demonstrated significant procedural advantage of laser atherectomy in the largest randomized trial of atherectomy ever conducted.
SilverHawk Plaque Excision: Early Experience in Infrapopliteal Disease and Limb Salvage, Vascular Interventional Advances (VIVA), Mandalay Bay, NE, October 19, 2000.. Second Annual Primer on Peripheral Arterial Disease: An Interventional Course for Advanced Angioplasty Fellows, Cincinnati, OH, September 12-13, 2000.. First Annual Primer on Peripheral Arterial Disease: An Interventional Course for Advanced Angioplasty Fellows, Cincinnati, OH, September 8-11, 1999.. Acute Coronary Syndrome, University of Cincinnati, Cincinnati, OH, May 1999 ...
Fingerprint Dive into the research topics of Balloon postdilation can safely improve the results of successful (but suboptimal) directional coronary atherectomy. Together they form a unique fingerprint. ...
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The companys Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted the first 510(k) clearance for the use of the Orbital Atherectomy System in peripheral arteries in August 2007. In October 2013, the company received FDA approval for the Coronary Orbital Atherectomy System. To date, over 356,000 of CSIs devices have been sold to leading institutions across the United States.
Blog post by bluespruce - Here are a few scanned photos of our previous garden at Purewell, Christchurch, in Dorset, as you can see the house and garden are typical Victorian t
Aortic & Peripheral Vascular net sales for the three and six months ended October 27, 2017 were $452 million and $891 million, respectively, an increase of 5 percent and 4 percent, respectively, as compared to the corresponding periods in the prior fiscal year. Aortic & Peripheral Vascular net sales growth for the three and six months ended October 27, 2017 was driven by strong performance in drug-coated balloons and success of the Endurant IIs aortic stent graft, as well as success of the Heli-FX EndoAnchor System. For the three months ended October 27, 2017, net sales growth was also driven by Percutaneous Transluminal Angioplasty (PTA) balloons and the recent launch of Concento 3D detachable coil system, as well as the Valiant Captiva thorasic stent graft systems. Continued strong adoption of the HawkOne 6 French directional atherectomy system also contributed to net sales growth for the three and six months ended October 27, 2017. ...
An elongate tubular body extends between a rotatable cutter and a control. The cutter is connected to the control with a rotatable element and has a serrated surface. A vacuum is applied through an annular passage defined between the tubular body and the rotatable element. The control has an indicator that reveals resistance to rotation and/or reduction in flow. Material that has been processed by the cutter is aspirated through the tubular body for disposal. The control enables rotation of the rotatable element only following application of a predetermined level of vacuum.
cleared coronary balloon on the market-is critical for physicians treating highly complex coronary lesions. As the market leader in coronary atherectomy, the 1.0mm balloon complements our orbital atherectomy system as we continue providing advanced solutions for treating the complex and high-risk indicated patient. At launch, CSI will offer both the 1.0-4.0mm Sapphire II PRO and the 2.0-4.0mm Sapphire® NC Plus non-compliant coronary balloons on a limited basis. The company anticipates that OrbusNeichs full balloon product portfolio will become available in the U.S. throughout 2018 and 2019. About OrbusNeich OrbusNeich is a global pioneer in the provision of life-changing vascular solutions and offers an extensive portfolio of products that set industry benchmarks in vascular intervention. Current products include the worlds first dual therapy stents, the COMBO Plus and COMBO Dual Therapy Stents, together with stents and balloons marketed under the names of Azule®, Scoreflex®, Sapphire® ...
Anna-Maria Belli speaks about how important it is that interventional radiologys clinical responsibility is acknowledged by IR having admitting rights, beds, junior teams and clinics.
TemREN is used to prepare the lesion area for balloon angioplasty and to relieve heavy plaque burden from atherosclerotic lesions. TemREN is usually made up of art...
Insights from the authors on removing severe superficial calcium to achieve significant luminal gain in femoropopliteal arteries.
EMEA (Europe, Middle East, Africa). In July 2018, Cardiovascular Systems, Inc. (CSI®) announced that OrbusNeich Medical Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems outside the United States and Japan.. Medikit Co., Ltd:. →Japan. In November 2016, Cardiovascular Systems, Inc. (CSI®) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.. ...
EMEA (Europe, Middle East, Africa). In July 2018, Cardiovascular Systems, Inc. (CSI®) announced that OrbusNeich Medical Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems outside the United States and Japan.. Medikit Co., Ltd:. →Japan. In November 2016, Cardiovascular Systems, Inc. (CSI®) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.. ...
Fumedica AG, Atherectomy, Ballon, Bergebeutel, Chirurgische Messer, Clips, Fixationen für Katheter, Hämorrhoidalleiden, Herniennetze, Herzunterstützung, Lungenunterstützung, Inkontinenz, Kardiotechnik, WarmAir, Blanketrol III, Nahtmaterial, Occluder, Patientenüberwachung, Ports, Sternumverschluss, Teflon Pledgets, Stent, Patienten Lagerung Proneview, Zangen, Instrumente
Sharma, Samin K.; Kini, Annapoorna S. (1999). "Coronary Atherectomy". Contemporary Concepts in Cardiology. Developments in ...
Atherectomy, in which the plaque is scraped off of the inside of the vessel wall (albeit with no better results than ... Any blood flow-limiting blockage found in the X-ray can be identified and treated by procedures including atherectomy, ... Procedures used to treat the disease include bypass grafting, angioplasty, and atherectomy. In 2015, about 155 million people ... "Atherectomy for peripheral arterial disease". The Cochrane Database of Systematic Reviews. 9: CD006680. doi:10.1002/14651858. ...
Often, peripheral angioplasty is used in conjunction with guide wire, peripheral stenting and an atherectomy. Angioplasty can ... "Percutaneous Angioplasty Versus Atherectomy for Treatment of Symptomatic Infra-Popliteal Arterial Disease". Cardiovascular ...
"Aminophylline for Preventing Bradyarrhythmias During Orbital or Rotational Atherectomy of the Right Coronary Artery". ... Atherectomy of the right coronary artery]. It is also used in the treatment of heart block due to acute inferior myocardial ...
He is the first cardiologist in the region to perform an angioscopy and directional atherectomy. He is reported to be the first ... Atherectomy Drug Eluting Stents Ventricular assist device Angioscopy Embolectomy Transmyocardial revascularization India portal ...
An atherectomy is an invasive procedure performed for removing atherosclerosis from blood vessels within the body. The narrowed ...
It is a form of PCI and generally what is implied when referring to "PCI." Atherectomy - Enlarging the lumen of an artery by ...
... including balloon angioplasty and atherectomy. Drug-eluting stents (DES) have also been extensively studied, and are generally ...
This procedure is different from Rotoblation (Percutaneous Transluminal Rotational Atherectomy or PCRA) whereby a diamond ... STENTS AND ATHERECTOMY (Cleveland Clinic) v t e. ...
... atherectomy MeSH E02.148.050.120.125 - atherectomy, coronary MeSH E02.148.102.060 - angioplasty, balloon MeSH E02.148.102.060. ...
Percutaneous angioplasty or atherectomy of precerebral (extracranial) vessel(s) (01) Incision and excision of skull, brain, and ...
... is a medical technique for visualizing the interior of blood vessels. In this technique, a flexible fiberoptic catheter inserted directly into an artery.[1] It can be helpful in diagnosing e.g. arterial embolism.[1] Angioscopy is also used as an adjunctive procedure during vascular bypass to visualize valves within venous conduits. The instrument used to perform angioscopy is called as angioscope. Coronary artery angioscopy, which first was used to reveal the presence of a blood clot in the coronary arteries of patients with unstable angina and myocardial infarction,[2] is now widely used in catherization laboratories to visualize stents. ...
After completion of surgery, the patient is transferred to the post anesthesia care unit and closely monitored. When the patient is judged to have recovered from the anesthesia, he/she is either transferred to a surgical ward elsewhere in the hospital or discharged home. During the post-operative period, the patient's general function is assessed, the outcome of the procedure is assessed, and the surgical site is checked for signs of infection. There are several risk factors associated with postoperative complications, such as immune deficiency and obesity. Obesity has long been considered a risk factor for adverse post-surgical outcomes. It has been linked to many disorders such as obesity hypoventilation syndrome, atelectasis and pulmonary embolism, adverse cardiovascular effects, and wound healing complications.[11] If removable skin closures are used, they are removed after 7 to 10 days post-operatively, or after healing of the incision is well under way. It is not uncommon for surgical ...
... is a palliative surgical procedure performed for patients with Tricuspid atresia. It is also part of the surgical treatment path for hypoplastic left heart syndrome. [1][2][3] This procedure has been largely replaced by Bidirectional Glenn procedure. It connects the superior vena cava to the right pulmonary artery.[4] ...
The patient must be placed supine, without the head or any extremities dangling over the edge of the table. Measurement of ankle blood pressures in a seated position will grossly overestimate the ABI (by approximately 0.3). A Doppler ultrasound blood flow detector, commonly called Doppler wand or Doppler probe, and a sphygmomanometer (blood pressure cuff) are usually needed. The blood pressure cuff is inflated proximal to the artery in question. Measured by the Doppler wand, the inflation continues until the pulse in the artery ceases. The blood pressure cuff is then slowly deflated. When the artery's pulse is re-detected through the Doppler probe the pressure in the cuff at that moment indicates the systolic pressure of that artery. The higher systolic reading of the left and right arm brachial artery is generally used in the assessment. The pressures in each foot's posterior tibial artery and dorsalis pedis artery are measured with the higher of the two values used as the ABI for that leg.[2] ...
While most IVC filters are made of non-ferromagnetic materials, there are a few types that are weakly ferromagnetic. Accordingly, IVC filters fall under the MRI Safe and MRI Conditional categories depending mostly on type of material used during construction. Rarely will one find an MRI Not Safe IVC filter, as most of the steel, and other ferromagnetic material devices have been discontinued via the FDA. IVC filters are attached to the vena cava via hooks on their ends. Some are compression springs, which compress outward onto the side wall of the vena cava; however, they still have small hooks that retain their location. These hooks aid in the anchoring and healing process, as they allow the tissues to 'ingrow' around them, securing the IVC in place. It is unlikely, then, after 4 to 6 weeks of healing, that an MRI of 1.5 tesla, up to 3 tesla, will cause any level of dislodging to occur to the IVC filter. Studies of MR examination of both animals and humans, with implanted IVC filters, have not ...
The original procedure was named for Alfred Blalock, surgeon, Baltimore (1899-1964), Helen B. Taussig, cardiologist, Baltimore/Boston (1898-1986) and Vivien Thomas (1910-1985) who was at that time Blalock's laboratory technician. They all helped to develop the procedure. Taussig, who treated hundreds of infants and children with this disorder, had observed that children with a cyanotic heart defect and a patent ductus arteriosus (PDA) lived longer than those without the PDA. It therefore seemed to her that a shunt which mimicked the function of a PDA might relieve the tetralogy patients' poor oxygenation. In 1943, having broached the possibility of a surgical solution to Robert Gross of Boston without success, Taussig approached Blalock and Thomas in their Hopkins laboratory in 1943. According to the account of the original consultation between the three provided in Vivien Thomas' 1985 autobiography Partners of the Heart, Taussig carefully described the anomaly of Tetralogy of Fallot, but made ...
Often, peripheral angioplasty is used in conjunction with guide wire, peripheral stenting and an atherectomy. ...
Atherectomy. Popliteal artery entrapment syndrome. Portal hypertension. Portosystemic shunt. Pseudoaneurysm. Covered stent ...
... , or impedance plethysmography (IPG), is a non-invasive medical test that measures small changes in electrical resistance of the chest, calf or other regions of the body. These measurements reflect blood volume changes, and can indirectly indicate the presence or absence of venous thrombosis. This procedure provides an alternative to venography, which is invasive and requires a great deal of skill to execute adequately and interpret accurately. For the chest, the technique was developed by NASA to measure the split second impedance changes within the chest, as the heart beats, to calculate both cardiac output and lung water content. This technique has progressed clinically (often now called BioZ, i.e. biologic impedance, as promoted by the leading manufacturer in the US) and allows low cost, non-invasive estimations of cardiac output and total peripheral resistance, using only 4 skin electrodes, oscillometric blood pressure measurement and lung water volumes with minimal ...
Atherectomy, stenting, and angioplasty to remove or push aside the arterial blockages are the most common procedures for ...
The apparatus, called a pullback atherectomy catheter, cuts and collects obstructive material into a collection chamber as the ... An atherectomy apparatus and method is disclosed for the purpose of surgical excision of atheromas which typically consist of ... Atherectomy device. US5085662 *. Nov 13, 1989. Feb 4, 1992. Scimed Life Systems, Inc.. Atherectomy catheter and related ... Medical instrument for atherectomy. US5728129 *. Jun 7, 1995. Mar 17, 1998. American Biomed, Inc.. Distal atherectomy catheter ...
An atherectomy system for cutting, ingesting and removing an obstruction from within a patients artery, comprising a flexible ... 2 shows a distal end of the atherectomy system.. FIG. 3 shows a cross sectional view of the atherectomy system along a line 3-- ... Cutter for atherectomy catheter. US5417703 *. 13 Jul 1993. 23 May 1995. Scimed Life Systems, Inc.. Thrombectomy devices and ... Medical instrument for atherectomy. US5916227 *. 11 Jul 1997. 29 Jun 1999. Scimed Life Systems, Inc.. Ablation devices and ...
... Devices, Applications, Competitive Analysis, Industry Expansion ... Directional atherectomy, Rotational atherectomy, Laser atherectomy, and Orbital atherectomy. Directional atherectomy catheter ... Directional Atherectomy. Rotational Atherectomy. Orbital Atherectomy. Laser Atherectomy. To get incredible discounts on this ... market-analysis-by-type-directional-atherectomy-rotational-atherectomy-orbital-atherectomy-laser-atherectomy-by-region-north- ...
... and the spaced-apart positioning of the chambers provides for stable positioning of the housing during atherectomy procedures, ... Directional atherectomy device with flexible housing. US5628761 *. 28 Jun 1995. 13 May 1997. Rizik; David G.. Guide wire ... Atherectomy catheter and RF cutting method. US5728123 *. 26 Apr 1995. 17 Mar 1998. Lemelson; Jerome H.. Balloon actuated ... Atherectomy catheter with aligned imager. US9687266. 27 Apr 2010. 27 Jun 2017. Covidien Lp. Methods and devices for cutting and ...
An atherectomy catheter is provided having a tissue collection chamber capable of being cleaned out in a simple, fast and ... Cutter for atherectomy device. US4894051 *. 19 dec 1988. 16 jan 1990. Surgical Systems & Instruments, Inc.. Atherectomy system ... Easily cleaned atherectomy catheters and methods of use. US8597315. 1 jul 2010. 3 dec 2013. Covidien Lp. Atherectomy catheter ... Occlusion-crossing devices, atherectomy devices, and imaging. US9345510. 1 jul 2011. 24 maj 2016. Avinger, Inc.. Atherectomy ...
Evidence-based recommendations on percutaneous laser atherectomy with balloon angioplasty (with or without stenting) for ... Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease ...
Evidence-based recommendations on percutaneous laser atherectomy with balloon angioplasty (with or without stenting) for ... Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease ... Scotland and Northern Ireland on Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting ...
In this report, the United States Laser Atherectomy Devices market... ... 96 Pages Report] Check for Discount on United States Laser Atherectomy Devices Market Report 2017 report by QYResearch Group. ... United States Laser Atherectomy Devices Market Report 2017 Table of Contents. United States Laser Atherectomy Devices Market ... 1 Laser Atherectomy Devices Overview. 1.1 Product Overview and Scope of Laser Atherectomy Devices. 1.2 Classification of Laser ...
Expandable tip atherectomy method and apparatus US5308354A (en) * 1991-07-15. 1994-05-03. Zacca Nadim M. Atherectomy and ... Atherectomy devices and methods US20080004645A1 (en) * 2006-06-30. 2008-01-03. Atheromed, Inc.. Atherectomy devices and methods ... Atherectomy device handle with guide wire clamp override device US6270509B1 (en) 2001-08-07. Cancave atherectomy burr with ... Atherectomy devices, systems, and methods US8888801B2 (en) 2006-06-30. 2014-11-18. Atheromed, Inc.. Atherectomy devices and ...
19 depicts a positioning atherectomy guide catheter; FIG. 20 depicts an atherectomy catheter having an atherectomy assembly as ... 12C depicts the atherectomy assembly of FIG. 12B as viewed from its distal tip; FIG. 13A depicts an atherectomy assembly in ... 13B depicts the atherectomy assembly of FIG. 13A viewed from above; FIG. 13C depicts the atherectomy assembly of FIG. 13B with ... 16C shows the atherectomy assembly of FIG. 16A as viewed from its distal end, while FIG. 16D shows the atherectomy assembly of ...
Atherectomy in peripheral artery disease: a review. J Invasive Cardiol. 2017;29(4):135-144. ... Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. 2006;48(8):1573-1578. ... Directional atherectomy had been contraindicated in restenotic stented lesions due to the potential risk of cutter entrapment ... At this point, the plan was to attempt to dislodge the atherectomy catheter from the stent struts by adjacent balloon inflation ...
Global Laser Atherectomy Devices Market: Regional Analysis. The global Laser Atherectomy Devices market has been segmented by ... Global Laser Atherectomy Devices Market which allows the consumer to assess the long-term based demand and estimate particular ... Global Laser Atherectomy Devices market research report provides the newest industry data and industry future trends. It ... The Laser Atherectomy Devices industry report lists the leading competitors and provides the game-changing strategic analysis ...
The atherectomy instrument is visualized within the coronary artery shaving away the atherosclerotic plaque . ... Description: This medical exhibit illustrates the Atherectomy Procedure. The atherectomy instrument is visualized within the ... This medical exhibit illustrates the Atherectomy Procedure. The atherectomy instrument is visualized within the coronary artery ... This medical exhibit illustrates the Atherectomy Procedure. ...
Chapter 11, The Consumers Analysis of Global Orbital Atherectomy Device ;. Chapter 12, Orbital Atherectomy Device Research ... Chapter 1, Definition, Specifications and Classification of Orbital Atherectomy Device, Applications of Orbital Atherectomy ... Orbital Atherectomy Device Segment Market Analysis (by Type);. Chapter 7 and 8, The Orbital Atherectomy Device Segment Market ... The global Orbital Atherectomy Device market report offers precise investigation for the market fluctuations. It gives a ...
Laser Atherectomy Devices, Laser Atherectomy Devices Market, Laser Atherectomy Devices Market Sale & Price, Laser Atherectomy ... The Laser Atherectomy Devices Market study gives data with n-number of tables and figures examining the Laser Atherectomy ... Laser Atherectomy Devices Market Size & Share, Laser Atherectomy Devices Market Trend Related Articles. ... Laser Atherectomy Devices report has focused on each region market size in terms of US$ Mn for each segment and sub-segment for ...
... or directional coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve ... DCA, or directional coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve ...
Phoenix atherectomy system (Volcano) is another rotational atherectomy system that continuously cuts, captures, and clears the ... The Collaborative Rotablator Atherectomy Group (CRAG). Peripheral atherectomy with the rotablator: a multicenter report. J Vasc ... Current status of rotational atherectomy. JACC Cardiovasc Interv. 2014;7(4):345-53.CrossRefPubMedGoogle Scholar ... In: Rotational Atherectomy: concepts and practice. New York: McGraw-Hill; 2007. p. 333-47.Google Scholar ...
Rotational atherectomy device. US6010522 *. 24 Jul 1996. 4 Jan 2000. Embol-X, Inc.. Atherectomy device having trapping and ... Single lumen atherectomy catheter device. US4765332 *. 14 Jul 1986. 23 Aug 1988. Medinnovations, Inc.. Pullback atherectomy ... Atherectomy devices, systems, and methods. US20090018567 *. 30 Jun 2008. 15 Jan 2009. Artheromed, Inc.. Atherectomy devices, ... Atherectomy devices and methods. US9345511. 15 Oct 2012. 24 May 2016. Atheromed, Inc.. Atherectomy apparatus, systems and ...
TemREN is used to prepare the lesion area for balloon angioplasty and to relieve heavy plaque burden from atherosclerotic lesions. TemREN is usually made up of art...
Atherectomy devices, systems, and methods. US8647355. Nov 30, 2012. Feb 11, 2014. Atheromed, Inc.. Atherectomy devices and ... Atherectomy apparatus, systems and methods. US8888801. Aug 19, 2011. Nov 18, 2014. Atheromed, Inc.. Atherectomy devices and ... Atherectomy devices, systems, and methods. US9333007. Jun 26, 2015. May 10, 2016. Atheromed, Inc.. Atherectomy devices and ... Atherectomy apparatus, systems and methods. US9492192. Jun 30, 2008. Nov 15, 2016. Atheromed, Inc.. Atherectomy devices, ...
Atherectomy is a procedure that widens narrowed arteries by removing accumulated plaque using a flexible catheter having a ... What are the Types of Atherectomy?. There are four types of atherectomy depending on the type of device that is attached to the ... What is Atherectomy? Atherectomy simply means excision or removal of an atheroma.. An atheroma is an abnormal accumulation of ... Why is Atherectomy Done?. Atherectomy is done for the following indications: *To restore blood flow to the affected tissue or ...
Learn more about Turbo-Power Laser atherectomy catheter. View specifications, download support documents and discover related ... Laser atherectomy catheter Find similar products The Turbo-Power laser atherectomy catheter debulks the lesion in a single step ... JETSTREAM Atherectomy System can remove superficial calcium in severely calcified peripheral arteries. Abstract Poster, ISET ... Tissue Removal Assessment with Ultrasound of the SFA and Popliteal Study (TRUTH): Orbital Atherectomy Acute Date and ...
An unusual complication of atherectomy is the re-blockage of the artery (restenosis) that may occur later, especially if you ... Your doctor will discuss the specific risks and potential benefits of the recommended procedure with you.Atherectomy usually ...
First Atherectomy Performed With Spectranetics Turbo-Tandem Device. July 17th, 2009 Medgadget Editors Vascular Surgery ... After completion of the laser atherectomy and adjunct angioplasty, distal runoff was excellent with brisk TIMI 3 blood flow and ... The Turbo-Tandem System is a single-use, disposable device indicated for atherectomy of infrainguinal arteries. It is comprised ... and is designed to perform atherectomy and ablation of plaque in arterial lesions above the knee, primarily within the ...
Atherectomy/Angioplasty of Noncoronary Vessel. (Nonsurgical Revascularization of Noncoronary Vessel). Pronounced: ATH-er-EK-toe ... If you are planning to have an atherectomy or angioplasty, your doctor will review a list of possible complications, which may ... Atherectomy and angioplasty are methods that can be used to open arteries without surgery. ...
Atherectomy and angioplasty are methods that can be used to open arteries without surgery. Learn about the reasons for these ... Atherectomy - The plaque is removed using a rotating shaver or laser.. Immediately After Procedure. Recovery time is minimal. ... If you are planning to have an atherectomy or angioplasty, your doctor will review a list of possible complications, which may ... Atherectomy and angioplasty are methods that can be used to open arteries without surgery. ...
Learn more about ELCA Coronary laser atherectomy catheter. View specifications, download support documents and discover related ... Coronary laser atherectomy catheter Find similar products ELCA coronary laser atherectomy catheters are designed to cross, ... This non-mechanical atherectomy catheter can be delivered over any .014" wire and can de-bulk and modify plaque of multiple ... morphologies and is approved for the broadest range of coronary indications in atherectomy. ...
The simulated Atherectomy devices include Atherectomy catheter and Burr systems. The trainee can operate the actual handles and ... ATHERECTOMY MODULE. This module allows clinicians to practice Atherectomy technique for treatment of stenosis in the ...
Coronary laser atherectomy catheter IGTDELCALASR Bekijk soortgelijke producten ELCA coronary laser atherectomy catheters are ... This non-mechanical atherectomy catheter can be delivered over any .014" wire and can de-bulk and modify plaque of multiple ... morphologies and is approved for the broadest range of coronary indications in atherectomy. ...
Paul, Minnesota) won the CE Mark to begin introducing its Stealth 360º Orbital Atherectomy System to the European market. ... The system consists of the following main components: Orbital Atherectomy Device, Saline Pump, Atherectomy guide wire and ... Stealth 360º Orbital Atherectomy System for PAD Cleared in Europe. November 5th, 2014 Editors Cardiology, Radiology, Vascular ... Paul, Minnesota) won the CE Mark to begin introducing its Stealth 360º Orbital Atherectomy System to the European market. ...
Rotational atherectomy by rotablator. The rotablator pulverize the calcified plaque of atheroma. Here, example of a coronary ... Caption: Rotational atherectomy by rotablator. The rotablator pulverize the calcified plaque of atheroma. Here, example of a ... Keywords: arteriosclerosis, artery, artwork, atherectomy, atheroma, blood circulation, blood vessel, cardio-vascular system, ... rotational atherectomy, science, sciences, stenosed artery, stenosis, surgery, vascular surgery, vascularization ...
Percutaneous transluminal rotational atherectomy for coronary artery disease. Atherosclerosis is the build-up of fat and other ... This is an update of the review on Percutaneous transluminal rotational atherectomy for coronary artery disease first ... Wasiak J, Law J, Watson P, Spinks A. Percutaneous transluminal rotational atherectomy for coronary artery disease. Cochrane ... Percutaneous transluminal coronary rotational atherectomy (PTCRA) debulks atherosclerotic plaque from coronary arteries using ...
Patients with complex femoropopliteal in-stent restenosis lesions benefited from treatment with laser atherectomy and a drug- ... Treatment with DCB, laser atherectomy beneficial in PAD, restenosis. Kokkinidis DG, et al. J Endovasc Ther. 2018;doi:10.1177/ ... "Laser atherectomy and DCB angioplasty have synergistic mechanisms of action that result in the large, clinically meaningful ... "Laser atherectomy and DCB angioplasty have synergistic mechanisms of action that result in the large, clinically meaningful ...
Meer informatie over ELCA Coronary laser atherectomy catheter. Bekijk specificaties, download ondersteuningsdocumenten en ... Coronary laser atherectomy catheter Bekijk soortgelijke producten ELCA coronary laser atherectomy catheters are designed to ... This non-mechanical atherectomy catheter can be delivered over any .014" wire and can de-bulk and modify plaque of multiple ... morphologies and is approved for the broadest range of coronary indications in atherectomy. ...
Cardiovascular Systems (NSDQ:CSII) said today that it inked an agreement with Aerolase to develop a laser atherectomy system ... Home » Cardiovascular Systems, Aerolase ink joint laser atherectomy dev deal. Cardiovascular Systems, Aerolase ink joint laser ... "We are excited to pursue the development of an atherectomy laser device with an industry-leading company like CSI. Our ... We look forward to demonstrating that our solid-state, patented, air-cooled laser technology can transfer to atherectomy and ...
Procedure: Immediate rotational atherectomy (RA) Procedure: Delayed rotational atherectomy (RA) Phase 1 Phase 2 ... Experimental: Rotational atherectomy (RA) Immediate rotational atherectomy (RA) in the treatment with nondilatable calcified ... Coronary artery dissection is a contraindication for the use of rotational atherectomy, since rotational atherectomy may ... Safety and Efficacy of Rotational Atherectomy (RA) in Coronary Dissection. The safety and scientific validity of this study is ...
Learn more about Phoenix atherectomy system Rotational atherectomy system. View specifications, download support documents and ... Phoenix atherectomy system Rotational atherectomy system Najít podobné výrobky The Phoenix atherectomy system combines the ... 3. The Phoenix atherectomy 1.8 mm tracking catheter is indicated for vessels 2.5 mm in diameter or above. The Phoenix ... 1. Rotational atherectomy refers to the Phoenix family of products. 2.4mm deflecting catheter and 2.2 mm auto-deflected ...
Lumivascular Optical Coherence Tomography-Guided Atherectomy in Recurrent Femoropopliteal Occlusive Diseases Associated with In ... This study reports our initial experience on the use of lumivascular OCT-guided atherectomy in the management of two patients ... Endovascular procedures were successful with a Pantheris atherectomy device (Avinger, Redwood City, CA, USA) and drug-eluting ... Lumivascular Optical Coherence Tomography-Guided Atherectomy in Recurrent Femoropopliteal Occlusive Diseases Associated with In ...
Keywords: Myocardial Infarction, Plaque, Atherosclerotic, Atherectomy, Coronary, Death, Sudden, Coronary Disease, Constriction ... Fifty-eight percent of all atherectomy procedures performed at the study centers were included in the trial.. Angiographic ... Lesion suitable for either atherectomy or angioplasty.. Exclusions: Restenosed lesions. Lesion length of > 10mm. Ostial or ... One sudden death occurred in a patient who had undergone atherectomy, and there were two myocardial infarctions, both in ...
Atherectomy is an excision or removal of an atheroma. It is a procedure that utilizes a catheter with a sharp blade on the end ... to remove plaque from blood vessels.The global atherectomy devices market report has been segmented on the basis of type, ... rotational atherectomy, orbital atherectomy, and laser atherectomy. The directional atherectomy devices segment is expected to ... Based on type, the global atherectomy devices market is segmented based on directional atherectomy, ...
An atherectomy catheter including a flexible casing, an elongated flexible tubular coil in the casing, a window extending ... An atherectomy catheter device including a flexible casing, an elongated flexible tubular coil in the casing, a window ... Atherectomy device having a flexible housing US4979951A (en) * 1984-05-30. 1990-12-25. Simpson John B. Atherectomy device and ... Atherectomy device having a flexible housing US4979951A (en) * 1984-05-30. 1990-12-25. Simpson John B. Atherectomy device and ...
  • Global Laser Atherectomy Devices Market which allows the consumer to assess the long-term based demand and estimate particular implementations. (galusaustralis.com)
  • The increasing growth which is truly expected depending on the analysis gives comprehensive information on the global Laser Atherectomy Devices Market. (galusaustralis.com)
  • Global Laser Atherectomy Devices market research report provides the newest industry data and industry future trends. (galusaustralis.com)
  • The report checks out the global Laser Atherectomy Devices Market and acquaints readers with data related to revenue updates, volume, and predicted extension percentage of the global Laser Atherectomy Devices Market (2020 -2029). (galusaustralis.com)
  • The report gives a large-scale investigation of market dynamics and factors that manage the growth of the global Laser Atherectomy Devices Market. (galusaustralis.com)
  • The report checks high growth segments in the market and analyzes the best investment areas for stakeholders in the global Laser Atherectomy Devices Market. (galusaustralis.com)
  • The research report presents a comprehensive outlook on the Global Laser Atherectomy Devices Market contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. (electronicsindustryreports.com)
  • 1) This report provides a quantitative analysis of the current trends and estimations from 2017 to 2022 of the global Laser Atherectomy Devices market to identify the prevailing market opportunities. (electronicsindustryreports.com)
  • The SilverHawk plaque excision system is a forward-cutting, directional atherectomy device that consists of a rotating blade inside a tubular housing with a collection area. (missionvascularinstitute.com)
  • Directional: A directional atherectomy utilizes SilverHawk technology with carbide disks to remove plaque build-up. (missionvascularinstitute.com)
  • Which segments grab the most noteworthy attention in Atherectomy Devices Market in 2019 and beyond? (openpr.com)
  • Laser Atherectomy Devices report has focused on each region market size in terms of US$ Mn for each segment and sub-segment for the period from 2019 to 2025, considering the macro and micro environmental factors. (electronicsindustryreports.com)
  • The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease. (nice.org.uk)
  • The report involves the forecasts by 2020-2029 and analysis of significant industry trends, market size, market share forecasts, and profiles of the top Laser Atherectomy Devices industry players. (galusaustralis.com)
  • The Laser Atherectomy Devices Market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability.It furthermore has an assessment of the factors influencing the demand and supply of the associated products and services, and challenges witnessed by market players. (electronicsindustryreports.com)
  • The Laser Atherectomy Devices Market study gives data with n-number of tables and figures examining the Laser Atherectomy Devices, the research gives you a visual, one-stop breakdown of the leading products, submarkets and market leader's market contribution in terms of volume produced (in kilo tons) and the revenue it generates (in US$) forecasts as well as analysis to 2025. (electronicsindustryreports.com)
  • The Laser Atherectomy Devices research report includes the products that are currently in demand and available in the market along with their cost breakup, manufacturing volume, import/export scheme and contribution to the Laser Atherectomy Devices market revenue worldwide. (electronicsindustryreports.com)
  • This invention relates generally to atherectomy devices and more specifically to such devices with a housing having a rotating helical cutter. (google.com)
  • The drivers and restraints are preparing after the whole awareness of the global Laser Atherectomy Devices industry growth. (galusaustralis.com)
  • The Laser Atherectomy Devices industry report lists the leading competitors and provides the game-changing strategic analysis of the key factors driving the market. (galusaustralis.com)
  • What will the market growth rate, Overview, and Analysis by Type of Laser Atherectomy Devices Market in 2029? (galusaustralis.com)
  • This Overview Includes Analysis of Scope, and price analysis of top Manufacturers Profiles of Laser Atherectomy Devices. (galusaustralis.com)
  • What are the key factors driving, Analysis by Applications and Countries Global Laser Atherectomy Devices industry? (galusaustralis.com)
  • Who are the opportunities and threats faced by the vendors in Laser Atherectomy Devices Market? (galusaustralis.com)
  • Who are Opportunities, Risk, and Driving Force of Laser Atherectomy Devices Market? (galusaustralis.com)
  • The report also includes the demand/supply prospects of the Laser Atherectomy Devices Market across the globe. (galusaustralis.com)
  • The Laser Atherectomy Devices market report begins with a market overview combining the data integration and analysis capabilities with the relevant findings, the report has predicted strong future growth of the market. (electronicsindustryreports.com)
  • With the help of inputs and insights from technical and marketing experts, the report presents an objective assessment of the Laser Atherectomy Devices market. (electronicsindustryreports.com)
  • Laser: A laser atherectomy uses a fiber catheter equipped with a laser tip that breaks up artery plaque by emitting high-frequency light via the laser. (missionvascularinstitute.com)
  • Browse market information, tables and figures and in-depth TOC on "Atherectomy Devices Market by Application, by Product Type, Business scope, Manufacturing and Outlook - Estimate to 2027. (openpr.com)
  • An orbital atherectomy utilizes a diamond-coated tungsten crown that orbits 360 degrees eccentrically within the vessel and uses circumferential sanding to remove plaque buildup. (missionvascularinstitute.com)
  • The Latest research study released by Reports and Data titled " Atherectomy Devices Market" with 200+ pages of analysis on business strategy taken up by key and emerging industry players delivers the details of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. (openpr.com)
  • The report Atherectomy Devices matches the examined and evaluated data of the noticeable companies and their situation in the market. (openpr.com)
  • The Atherectomy Devices market report is a database of industry-related information, which extends to all crucial market aspects including invaluable facts and figures, latest technological advancements, and insights into the sector gathered from industry professionals with firsthand experience of the functioning of the industry. (openpr.com)
  • Who are the key players in the Atherectomy Devices Market? (openpr.com)
  • What are the most encouraging, high-development scenarios for Atherectomy Devices growth based on applications, types, and regions? (openpr.com)
  • During an atherectomy, an incision is made in an artery and a catheter is threaded up through the artery to the position of the blockage. (google.com)
  • Percutaneous rotational and aspirational atherectomy in infrainguinal peripheral arterial occlusive disease: a mutlicenter pilot study. (springer.com)
  • One-year outcome after percutaneous rotational and aspiration atherectomy in infrainguinal arteries in patient with and without type 2 diabetes mellitus. (springer.com)
  • Several methods are used to remove this build-up including a procedure known as percutaneous transluminalcoronary rotational atherectomy (PTCRA). (cochrane.org)
  • This is an update of the review on 'Percutaneous transluminal rotational atherectomy for coronary artery disease' first published in The Cochrane Library Issue 4, 2003. (cochrane.org)
  • Percutaneous transluminal coronary rotational atherectomy (PTCRA) debulks atherosclerotic plaque from coronary arteries using an abrasive burr. (cochrane.org)
  • This study is aimed at examining the safety and efficacy of rotational atherectomy (RA) in nondilatable calcified lesion complicated by coronary dissection during percutaneous coronary intervention (PCI) procedure. (clinicaltrials.gov)
  • Mechanical rotational atherectomy with the Rotablator is widely used for percutaneous coronary revascularization, but the ideal debulking strategy remains unknown. (nih.gov)
  • The therapy is intended for patients who are acceptable candidates for percutaneous transluminal atherectomy. (centerwatch.com)
  • The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease. (nice.org.uk)
  • The study, which is said to be the first multi-center, randomized prospective trial ever conducted for the treatment of ISR, demonstrated highly superior safety and efficacy of laser atherectomy with adjunctive percutaneous transluminal angioplasty (PTA) compared with PTA alone. (bioopticsworld.com)
  • Coronary atherectomy, endoluminal stenting, and laser angioplasty are alternative interventions to balloon angioplasty (PTCA) for the percutaneous revascularization of obstructive CAD. (acpjc.org)
  • METHODS: Clinical data of all consecutive patients treated with percutaneous atherectomy utilizing the SilverHawk™ plaque excision was retrospectively analyzed. (minervamedica.it)
  • Aim: The study objective was to examine the application of excimer laser atherectomy (ELA) in patients with refractory occlusions in femoropopliteal arteries, where the initial conventional percutaneous transluminal angioplasty (PTA) recanalization attempts, were unsuccessful. (minervamedica.it)
  • 1 Endovascular treatment of symptomatic PAD has traditionally been performed with percutaneous balloon angioplasty (PTA) and, more recently, with various modes of atherectomy and stenting. (vasculardiseasemanagement.com)
  • The DIAMONDBACK 360® Coronary Orbital Atherectomy Systems (OAS) are percutaneous orbital atherectomy systems indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo , severely calcified coronary artery lesions. (csi360.com)
  • Shammas NW, Shammas GA, Banerjee S, Popma JJ, Mohammad A, Jerin M. JetStream rotational and aspiration Atherectomy in treating in-stent restenosis of the Femoropopliteal arteries: results of the JETSTREAM-ISR feasibility study. (springer.com)
  • Randomized Controlled Study of Excimer Laser Atherectomy for Treatment of Femoropopliteal In-stent Restenosis: Initial EXCITE ISR Results (2015). (philips.com)
  • An unusual complication of atherectomy is the re-blockage of the artery (restenosis) that may occur later, especially if you smoke cigarettes.Special precautions are taken to decrease these risks, and there may be other possible risks. (clevelandclinic.org)
  • This study reports our initial experience on the use of lumivascular OCT-guided atherectomy in the management of two patients with recurrent restenosis in their femoropopliteal arteries associated with in-stent restenosis. (dovepress.com)
  • The rate of restenosis was 46 percent in the atherectomy group (95 percent confidence interval, 37 to 54 percent) and 43 percent in the angioplasty group (95 percent confidence interval, 34 to 52 percent) (P = 0.71). (acc.org)
  • Although the procedural success rate was somewhat higher and the postprocedure lumen larger in patients treated with atherectomy, lumen dimensions, restenosis rates and clinical outcomes were similar in the two groups at six months. (acc.org)
  • These features make laser atherectomy an efficient tool in the treatment of peripheral arteries with higher atherosclerotic burden and thrombus, as well as in the treatment of diffuse intimal hyperplasia that is seen with in-stent restenosis of previously stented peripheral arteries. (springer.com)
  • Directional atherectomy was associated with a trend toward lower rates of restenosis at 6 months, and increased mortality and ischemic events at one year. (acc.org)
  • Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. (thefreedictionary.com)
  • Our CVX-300(R) excimer laser is the only system approved by the FDA for multiple cardiovascular procedures, including coronary atherectomy , the treatment of in-stent restenosis prior to radiation therapy, and the removal of problematic pacemaker and defibrillator leads. (thefreedictionary.com)
  • Spectranetics, an excimer laser maker, has received FDA approval for its Turbo-Tandem and Turbo Elite peripheral laser atherectomy products to treat in-stent restenosis (ISR). (bioopticsworld.com)
  • The investigator initiated DEFINITVE AR (Directional AthErectomy Followed by a PaclItaxel-Coated BallooN to InhibiT RestenosIs and maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment) trial to assess and estimate the effect of treating a vessel with directional atherectomy followed by DCB angioplasty compared with treatment with DCB alone. (hospitalhealthcare.com)
  • Patients in the atherectomy group showed a trend toward a lower rate of restenosis at 6 months (50% vs 57%, P = 0.06). (acpjc.org)
  • The studies by Topol and Adelman and their colleagues tested the hypothesis that directional coronary atherectomy (DCA) is superior to PTCA in reducing restenosis. (acpjc.org)
  • Despite initial claims by atherectomy enthusiasts and persistent claims by industry representatives that CAVEAT showed lower restenosis rates with DCA, the published studies clearly show no clinical advantage for DCA as a general primary intervention strategy. (acpjc.org)
  • In this prospective pilot study, a total of 15 patients were evaluated by intravascular ultrasound (IVUS) following treatment of femoropopliteal de novo or non-stent restenosis using atherectomy. (invasivecardiology.com)
  • Atherectomy has not been shown to be superior to angioplasty in reducing target-lesion revascularization (TLR) or restenosis, 8 which may be partly explained by undetected deeper dissections on an angiogram. (invasivecardiology.com)
  • A total of 15 patients undergoing atherectomy of the femoropopliteal arteries for de novo or restenotic disease (non-stent restenosis) were prospectively included in this study by one operator at one center. (invasivecardiology.com)
  • The Turbo-Power laser atherectomy catheter debulks the lesion in a single step and offers remote automatic rotation for precise directional control. (philips.com)
  • Lesion suitable for either atherectomy or angioplasty. (acc.org)
  • The Company is pleased to announce that the United States Food and Drug Administration has granted approval to include the use of atherectomy for lesion preparation in its ongoing Chocolate Touch® drug-coated balloon pivotal study and addition of subgroup analysis related to the use of atherectomy. (pharmiweb.com)
  • Successful debulking with the Jetstream Atherectomy System in a distal right SFA/proximal popliteal artery lesion. (bostonscientific.com)
  • DEFINITIVE AR was designed to assess the effect of treating a lesion with directional atherectomy (Medtronic/Covidien's SilverHawk or TurboHawk plaque excision systems) followed by a paclitaxel-coated balloon (Bayer HealthCare's peripheral paclitaxel-coated angioplasty catheter with Paccocath Technology), collectively referred to as DAART (directional atherectomy + anti-restenotic therapy), in order to generate early hypotheses for further research in this therapy area. (cxsymposium.com)
  • Rotational atherectomy can be used in such situations to shave off stent struts and the underlying resistant plaque, and enable placement and appropriate expansion of the original lesion and/or a second stent. (cancertherapyadvisor.com)
  • Results of this study ("Primary lesion treatment with an orbital atherectomy system enhances paclitaxel deposition in calcified peripheral arteries") were presented yesterday by Elazer Edelman, M.D., Ph.D., Chairman and co-founder of CBSET, in a dedicated session, "Peripheral interventions", at the "EuroPCR 2015" annual scientific meeting in Paris. (cbset.org)
  • Directional atherectomy works by using a special catheter designed for lesion cutting at the site of the blockage. (pittsburghveins.com)
  • An atherectomy apparatus and method is disclosed for the purpose of surgical excision of atheromas which typically consist of plaque deposits that cause narrowing (stenosis) of an artery. (google.com)
  • The apparatus, called a pullback atherectomy catheter, cuts and collects obstructive material into a collection chamber as the catheter is pulled back through obstructive material within a human vessel such as an artery. (google.com)
  • Analysis of retrieved particulate debris after superficial femoral artery (SFA) atherectomy using the Pathway Jetstream G3 device. (springer.com)
  • An atherectomy system for cutting, ingesting and removing an obstruction from within a patient's artery, comprising a flexible guide-wire insertable into the artery, a flexible rotary-catheter rotatably disposed and slidable over the flexible guide-wire, a blade forming a distal end of the flexible rotary-catheter. (google.ca)
  • This module allows clinicians to practice Atherectomy technique for treatment of stenosis in the Superficial Femoral Artery (SFA) and in infra-popliteal arteries. (simbionix.com)
  • Coronary artery dissection is a contraindication for the use of rotational atherectomy, since rotational atherectomy may propagate coronary dissection. (clinicaltrials.gov)
  • Atherectomy is a procedure that relieves symptoms of coronary artery disease by improving blood flow to your heart. (vidanthealth.com)
  • Then, a special atherectomy catheter carrying a grinding device is positioned at the narrow spot in your coronary artery. (vidanthealth.com)
  • ST. PAUL, Minn.--( BUSINESS WIRE )--Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Hong Kong has been treated with its Stealth 360 ® Peripheral Orbital Atherectomy System (OAS). (businesswire.com)
  • Coronary atherectomy or commonly referred to as rotablation, is a catheter-based procedure that includes a high-speed rotating metallic burr that abrades calcified (hardened) plaque that is blocking an artery and blood supply to the heart, rotating at speeds of up to 200,000 RPM. (thefreedictionary.com)
  • Atherectomy is a minimally invasive, catheter-based treatment for atherosclerosis and peripheral artery disease in the lower extremities. (gottliebhospital.org)
  • April 10, 2019-Avinger, Inc. announced that the company has received FDA 510(k) clearance for its Pantheris SV image-guided atherectomy system, which is indicated for the diagnosis and treatment of peripheral artery disease in small vessels (2-4 mm in diameter). (evtoday.com)
  • Avinger's Lumivascular technology uses an OCT that is displayed on the company's Lightbox console to allow physicians to see from inside the artery during an atherectomy procedure. (evtoday.com)
  • However, rotational atherectomy and to a much lesser degree, laser atherectomy continue to have significant niche roles in current management of obstructive coronary artery disease. (cancertherapyadvisor.com)
  • A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. (acpjc.org)
  • To compare clinical outcomes after directional atherectomy and angioplasty for patients with coronary artery disease (CAD). (acpjc.org)
  • During an atherectomy, an incision is made in an artery and a catheter is threaded up through the artery to the position of the blockage. (google.com)
  • Rotational Atherectomy in a Dissected Coronary Artery That Propagated Into the Sinus of Valsalva: Is This the Last Hope? (medreviews.com)
  • MENLO PARK, CA - October 21, 2013 - AtheroMed, a developer of innovative catheter technologies for treating peripheral artery disease (PAD), announced results from its Endovascular Atherectomy Safety and Effectiveness (EASE) study during a Late Breaking Clinical Trials Session at the Vascular Interventional Advances (VIVA) 2013 conference in Las Vegas. (vertical-group.com)
  • In many cases, a stent will be inserted into your blocked artery after the atherectomy. (emedtv.com)
  • Results from the DEFINITIVE LE study using Covidien's TurboHawk and/or SilverHawk directional atherectomy systems demonstrated 95 percent limb salvage in patients with critical limb ischemia (CLI) and 78 percent overall patency (the ability for the treated artery to remain open) in claudicant patients at 12 months. (dicardiology.com)
  • The outcomes for patients with claudication reveal that in the scientific landscape directional atherectomy is not only safe but effective to a similar degree as previous trials in the superficial femoral artery (SFA). (dicardiology.com)
  • During an atherectomy, a physician clears a clogged artery by cutting, shaving or vaporizing the plaque that is blocking a blood vessel. (mercedvascular.com)
  • Atherectomy may be indicated in patients who have coronary artery disease or artery disease in other areas of the body. (mercedvascular.com)
  • DCA, or directional coronary atherectomy is a minimally invasive procedure to remove blockage from coronary arteries to improve blood flow to the heart muscle and ease pain. (medlineplus.gov)
  • The devices for directional atherectomy approved by the US FDA can be used only for peripheral blood vessels and not for the coronary, carotid, iliac, or renal arteries. (medindia.net)
  • JETSTREAM Atherectomy System can remove superficial calcium in severely calcified peripheral arteries. (philips.com)
  • Your doctor will discuss the specific risks and potential benefits of the recommended procedure with you.Atherectomy usually has no complications, but as with any surgery, there is a risk of complications, such as embolization (the dislodgement of debris that blocks the arteries in the lower part of the leg) and perforation. (clevelandclinic.org)
  • The Turbo-Tandem System is a single-use, disposable device indicated for atherectomy of infrainguinal arteries. (medgadget.com)
  • Atherectomy and angioplasty are methods that can be used to open arteries without surgery. (epnet.com)
  • The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital Atherectomy System in peripheral arteries in August 2007. (businesswire.com)
  • In October 2013, the company received FDA approval for the use of the Diamondback Orbital Atherectomy System in coronary arteries. (businesswire.com)
  • 4 Maehara A, Mintz G, Shimshak T, Ricotta J, Ramaiah V, Foster M, Davis T, Gray W. Intravascular ultrasound evaluation of JETSTREAM atherectomy removal of superficial calcium in peripheral arteries. (bostonscientific.com)
  • Atherectomy is a procedure used to remove plaque and open narrowed coronary arteries to clear heart blockages and increase blood flow. (gottliebhospital.org)
  • An atherectomy is especially helpful for treating blockages in arteries that occur around branches or in vessels that are not easily treated with stents . (gottliebhospital.org)
  • The Revolution device is indicated for atherectomy of the peripheral vasculature and to break apart and remove thrombus from the peripheral arteries. (mpo-mag.com)
  • The DEFINITIVE Ca++ (Determination of Safety and Effectiveness of the SilverHawk™ Peripheral Plaque Excision System for Calcium (SilverHawk LS-C) and the SpiderFX™ Embolic Protection Device for the Treatment of Calcified Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries) single arm trial demonstrated calcified disease can be treated effectively with directional atherectomy using an embolic protection device. (hospitalhealthcare.com)
  • furthermore, endoluminal‑driven atherectomy may effectively reduce the requirement for stent placement in the lower limb arteries and is associated with long‑term patency. (spandidos-publications.com)
  • Dissections occur post atherectomy of the infrainguinal arteries. (invasivecardiology.com)
  • An atherectomy is a procedure used to remove hardened blockages in the arteries of your heart. (emedtv.com)
  • If your doctor finds hardened blockages in your coronary arteries, an atherectomy may be used to remove the blockages with a special pulverizing device. (emedtv.com)
  • ORBIT II is evaluating the safety and effectiveness of the company's orbital atherectomy technology in treating severely calcified coronary arteries. (medlatest.com)
  • An atherectomy is a procedure that mechanically removes plaque and other debris that can block arteries throughout the body. (mercedvascular.com)
  • Atherectomy treats diseased coronoary (heart) arteries, but is used less commonly in arteries outside the heart. (mercedvascular.com)
  • An atherectomy is a procedure used to remove plaque-cholesterol and fibrous tissue that blocks arteries. (mercedvascular.com)
  • Today most atherectomy procedures are performed in the coronary (heart) arteries. (mercedvascular.com)
  • Far less commonly, physicians perform atherectomy in peripheral arteries (those in other parts of the body such as the legs). (mercedvascular.com)
  • The goal of atherectomy is to eliminate the buildup of plaque in the arteries. (brvsc.com)
  • Directional Atherectomy is a minimally invasive procedure to remove blockages from the arteries. (pittsburghveins.com)
  • Once the decision to perform an atherectomy is made, then as for any surgical procedure, several blood tests, urine tests and imaging tests will be carried out to assess your general health condition. (medindia.net)
  • Any abnormal test results such as underlying infection, uncontrolled blood sugar or low hemoglobin concentration (anemia) may have to be corrected with treatment before the atherectomy procedure. (medindia.net)
  • What Happens During the Atherectomy Procedure? (medindia.net)
  • If you and your doctor determine that atherectomy is the right treatment for you, the procedure will be performed under local anesthesia with a mild sedative. (gottliebhospital.org)
  • Therefore, the differentiation between superficial and deep calcification and their respective roles in severe stenosis is important when evaluating the true efficacy of any atherectomy procedure and device. (evtoday.com)
  • One way to treat atherosclerosis is a procedure known as an atherectomy. (google.com)
  • You will be given specific instructions on preparing for atherectomy and what to expect the day of and the days following the procedure. (emedtv.com)
  • The post-atherectomy images reveal a lumen area of 7.6 mm² and impressive debulking with Jetstream Atherectomy even before adjunctive therapy. (bostonscientific.com)
  • The long-term outcome of Jetstream atherectomy (JA) with or without adjunctive drug coated balloons (DCB) in a real-world setting remains unknown. (crtonline.org)
  • 001 for both baseline vs post atherectomy and post atherectomy vs adjunctive angioplasty). (invasivecardiology.com)
  • Phoenix atherectomy system (Volcano) is another rotational atherectomy system that continuously cuts, captures, and clears the atheroma with a low-profile catheter that can be used for below knee vessels. (springer.com)
  • An atherectomy catheter is provided having a tissue collection chamber capable of being cleaned out in a simple, fast and effective way, and also provides methods of using said catheter to remove material from a blood vessel lumen. (google.se)
  • The pre-atherectomy IVUS image reveals a lumen area of 2.5 mm². (bostonscientific.com)
  • 16 Directional atherectomy related lumen gain was 2.2mm, the bail-out stent rate was as low as 4.1%, flow-limiting dissections were found in 1.5% only. (hospitalhealthcare.com)
  • At the slice with the maximum calcium reduction, the lumen area increased from 6.6 ± 3.7 mm 2 preintervention to 10 ± 3.6 mm 2 ( P = .001) after atherectomy. (evtoday.com)
  • Therefore, the second lesson was that the JETSTREAM Atherectomy System increased lumen dimensions by calcium removal as well as by calcium modification (increase in reverberations). (evtoday.com)
  • Initially, atherectomy resulted in a greater gain in lumen size and a higher initial success rate (reduction to ≤ 50% stenosis) compared with angioplasty, but early complications were higher, costs were increased, and no clinical benefit was apparent at 6 months. (acpjc.org)
  • In addition, other approaches include a true lumen wire approach, which can be time consuming since passing the wire through the true lumen can be difficult, and a subintimal wiring approach, which does not perform debulking by atherectomy. (justia.com)
  • In addition, it would be desirable, if the method and dissecting device can save time by avoiding trying to pass a wire through the true lumen, lower the risk of dissection and perforation during PTA and stenting from the subintimal space, and provide for re-entry during atherectomy. (justia.com)
  • The FreedomFlow Orbital Circumferential Atherectomy System is a minimally invasive, catheter-based system designed for improving luminal diameter and modifying vessel wall compliance in patients with PAD. (centerwatch.com)
  • The OAS is contraindicated when the patient is not an appropriate candidate for bypass surgery, angioplasty, or atherectomy therapy, or has angiographic evidence of thrombus, or has only one open vessel, or has angiographic evidence of significant dissection at the treatment site and for women who are pregnant or children. (csi360.com)
  • A narrowed vessel can also be debulked by atherectomy to avoid the complications from PTA and stent treatment. (justia.com)
  • This further confirms the effectiveness and versatility of directional atherectomy in a wide range of vessel sizes and clinical presentations. (dicardiology.com)
  • Dissections post atherectomy are grossly under-appreciated on angiogram when compared to IVUS. (invasivecardiology.com)
  • Akkus N.I., Abdulbaki A. (2018) Laser Atherectomy in Peripheral Arterial Interventions. (springer.com)
  • In this report, the United States Laser Atherectomy Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. (reportsnreports.com)
  • Global Laser Atherectomy Devices Market which allows the consumer to assess the long-term based demand and estimate particular implementations. (galusaustralis.com)
  • The increasing growth which is truly expected depending on the analysis gives comprehensive information on the global Laser Atherectomy Devices Market. (galusaustralis.com)
  • Global Laser Atherectomy Devices market research report provides the newest industry data and industry future trends. (galusaustralis.com)
  • What will the market growth rate, Overview, and Analysis by Type of Laser Atherectomy Devices Market in 2029? (galusaustralis.com)
  • Who are the opportunities and threats faced by the vendors in Laser Atherectomy Devices Market? (galusaustralis.com)
  • Who are Opportunities, Risk, and Driving Force of Laser Atherectomy Devices Market? (galusaustralis.com)
  • The report checks out the global Laser Atherectomy Devices Market and acquaints readers with data related to revenue updates, volume, and predicted extension percentage of the global Laser Atherectomy Devices Market (2020 -2029). (galusaustralis.com)
  • The report gives a large-scale investigation of market dynamics and factors that manage the growth of the global Laser Atherectomy Devices Market. (galusaustralis.com)
  • The report checks high growth segments in the market and analyzes the best investment areas for stakeholders in the global Laser Atherectomy Devices Market. (galusaustralis.com)
  • The report also includes the demand/supply prospects of the Laser Atherectomy Devices Market across the globe. (galusaustralis.com)
  • 1012 patients (mean age 59 y, 73% men) with symptomatic CAD who were eligible for either atherectomy or angioplasty. (acpjc.org)
  • To compare directional atherectomy with coronary angioplasty. (acc.org)
  • We present data on the number and severity of dissections as seen on intravascular ultrasound (IVUS) following atherectomy based on the iDissection classification 9 and the National Heart, Lung and Blood Institute (NHLBI) classification for coronary dissections. (invasivecardiology.com)
  • Angiographic success was achieved in 135 of 138 patients undergoing atherectomy (98 percent) and 124 of 136 patients undergoing angioplasty (91 percent) (P = 0.017). (acc.org)
  • Atherectomy has been reported to reduce angiographic dissections and therefore bailout stenting. (invasivecardiology.com)
  • Rotational atherectomy by rotablator. (sciencephoto.com)
  • Coronary angioplasty and Rotablator atherectomy trial (CARAT): immediate and late results of a prospective multicenter randomized trial. (nih.gov)
  • Based on type, the global atherectomy devices market is segmented based on directional atherectomy, rotational atherectomy, orbital atherectomy, and laser atherectomy. (pharmiweb.com)
  • As with any surgery, complications can occur with an atherectomy, such as infections, blood clots, and kidney failure. (emedtv.com)
  • abstract = "Directional coronary atherectomy (DCA) was performed in 158 patients over a 2-year period at the Mayo Clinic. (elsevier.com)
  • Atherectomy simply means excision or removal of an atheroma. (medindia.net)
  • The global atherectomy devices market report has been segmented on the basis of type, application, end user, and region. (pharmiweb.com)
  • Increasing prevalence of cardiovascular diseases and increasing preference for minimally invasive surgical procedures are major factor expected to boost the growth of the global atherectomy devices market over the forecast period. (pharmiweb.com)
  • Global Atherectomy And Thrombectomy Devices Market Report 2019, Competitive Land. (marketstudyreport.com)
  • A new Global Atherectomy and Thrombectomy Devices Market research report is an in-depth study of Atherectomy and Thrombectomy Devices industry including essential frameworks. (dailycommercenews.com)
  • Global Atherectomy and Thrombectomy Devices market report highlights market revenue, share, growth and Atherectomy and Thrombectomy Devices market size . (dailycommercenews.com)
  • The Global Atherectomy and Thrombectomy Devices Market report includes an overall industry outline to provide clients with an entire idea of Atherectomy and Thrombectomy Devices market situation and its strategies. (dailycommercenews.com)
  • The Atherectomy and Thrombectomy Devices report also includes main point and facts of Global Atherectomy and Thrombectomy Devices Market with its sales and growth. (dailycommercenews.com)
  • Global Atherectomy and Thrombectomy Devices Market Report for 2018 aims to provide target audience with the recent outlook on Atherectomy and Thrombectomy Devices market and complete the knowledge gaps with the help of current information and opinions from industry expertize. (dailycommercenews.com)
  • Intravascular ultrasound evaluation of jetstream atherectomy removal of superficial calcium in peripheral disease. (springer.com)
  • Jetstream atherectomy with DCB is superior to Jetstreamatherectomy with PTA in treating femoropopliteal disease. (crtonline.org)
  • Intravascular hemolysis following peripheral atherectomy with the pathway Jetstream catheter. (springer.com)
  • The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Coronary Atherectomy Devices and Lower Extremity Peripheral Atherectomy Devices. (researchandmarkets.com)
  • Millions of patients with PAD may benefit from treatment with orbital atherectomy utilizing CSI's Peripheral Orbital Atherectomy Systems, minimally invasive catheter systems developed and manufactured by CSI. (cbset.org)
  • Standard endovascular revascularization therapy consisting of atherectomy with or without angioplasty and with or without stent placement. (clinicaltrials.gov)
  • These would be good cases for rotational atherectomy prior to stent placement. (cancertherapyadvisor.com)